Journal of Medicinal Chemistry · 2006 · 60 citations · 15 references
Life SciencesInfectious DiseasesMedicinal ChemistryMolecular VirologyNucleic Acid BiochemistryVirologyAntiviral AgentsAntiviral ImmunityAntiviral PharmacologyAntiviral TherapyInterferon ResponsesViral Rna BiologyAntiviral Structure-activity RelationshipsEnzyme Activity PotencyRna Virus BiologySubgenomic Viral RnaViral Protease InhibitionViral ProteasesViral Replication InhibitionViral Replication Inhibitors
Introduction of various modified prolines at P(2) and optimization of the P(1) side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K(i)*= 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC(50) and IC(90) of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.
15
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Volker Lohmann, Frank Körner, Jan Oliver Koch et al. · Science · 1999 · 2.8K citations
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sonia Sharma, Benjamin R. tenOever, Nathalie Grandvaux et al. · Science · 2003 · 1.7K citations
Genome-Scale Identification of Nucleosome Positions in <i>S. cerevisiae</i>
Guo‐Cheng Yuan, Yuen-Jong Liu, Michael F. Dion et al. · Science · 2005 · 1.2K citations
Alexander A. Kolykhalov, Kathy Mihalik, Stephen M. Feinstone et al. · Journal of Virology · 2000 · 592 citations · Full text
Positive Selection of Natural Autoreactive B Cells
Kyoko Hayakawa, Masanao Asano, Susan A. Shinton et al. · Science · 1999 · 570 citations